Prelude Therapeutics Inc — All Filings
358 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
3
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | PRIMARY DOCUMENT | 0001562180-25-002392 | Mar 14, 2025 | Mar 12, 2025 |
| S-8 | S-8 | 0000950170-25-035930 | Mar 10, 2025 | — |
| 8-K | 8-K | 0000950170-25-035917 | Mar 10, 2025 | — |
| 10-K | 10-K | 0000950170-25-035921 | Mar 10, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | — | 0000929638-25-000784 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001193805-25-000177 | Feb 13, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001562180-25-000956 | Feb 5, 2025 | Feb 4, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-000955 | Feb 5, 2025 | Feb 4, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-000957 | Feb 5, 2025 | Feb 4, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-000958 | Feb 5, 2025 | Feb 4, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-000960 | Feb 5, 2025 | Feb 4, 2025 |
| 8-K | 8-K | 0000950170-25-014543 | Feb 5, 2025 | Feb 3, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-000237 | Jan 7, 2025 | Jan 4, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-000031 | Jan 3, 2025 | Dec 31, 2024 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-000008 | Jan 2, 2025 | Dec 30, 2024 |
| 4 | PRIMARY DOCUMENT | 0001562180-24-008565 | Dec 26, 2024 | Dec 20, 2024 |
| 4 | PRIMARY DOCUMENT | 0001562180-24-008531 | Dec 20, 2024 | Dec 18, 2024 |
| 4 | PRIMARY DOCUMENT | 0001562180-24-008532 | Dec 20, 2024 | Dec 19, 2024 |
| 8-K | 8-K | 0000950170-24-135212 | Dec 11, 2024 | — |
| 8-K | 8-K | 0000950170-24-122337 | Nov 6, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-122377 | Nov 6, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0000950170-24-116853 | Oct 24, 2024 | — |
| 4 | PRIMARY DOCUMENT | 0001562180-24-007253 | Oct 7, 2024 | Oct 4, 2024 |
| 8-K | 8-K | 0000950170-24-106362 | Sep 13, 2024 | — |
| 8-K | 8-K | 0000950170-24-104575 | Sep 9, 2024 | — |
| 8-K | 8-K | 0000950170-24-095059 | Aug 12, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-095065 | Aug 12, 2024 | Jun 30, 2024 |
| 4 | PRIMARY DOCUMENT | 0001562180-24-005641 | Jul 8, 2024 | Jul 4, 2024 |
| 4 | 4 | 0000950170-24-074907 | Jun 18, 2024 | Jun 14, 2024 |
| 4 | PRIMARY DOCUMENT | 0001562180-24-005161 | Jun 18, 2024 | Jun 14, 2024 |
| 8-K | 8-K | 0000950170-24-074846 | Jun 18, 2024 | Jun 14, 2024 |
| 4 | PRIMARY DOCUMENT | 0001562180-24-005162 | Jun 18, 2024 | Jun 14, 2024 |
| 4 | PRIMARY DOCUMENT | 0001562180-24-005160 | Jun 18, 2024 | Jun 14, 2024 |
| 4 | PRIMARY DOCUMENT | 0001562180-24-005163 | Jun 18, 2024 | Jun 14, 2024 |
| 4 | PRIMARY DOCUMENT | 0001562180-24-005159 | Jun 18, 2024 | Jun 14, 2024 |
| 8-K | 8-K | 0000950170-24-072249 | Jun 12, 2024 | — |
| EFFECT | — | 9999999995-24-001804 | Jun 10, 2024 | — |
| CORRESP | — | 0001193125-24-156046 | Jun 6, 2024 | — |
| UPLOAD | — | 0000000000-24-006323 | Jun 3, 2024 | — |
| S-3 | S-3 | 0001193125-24-150375 | May 30, 2024 | — |
| 4 | PRIMARY DOCUMENT | 0001562180-24-004084 | May 16, 2024 | May 14, 2024 |
| 8-K/A | 8-K/A | 0000950170-24-061079 | May 16, 2024 | Apr 8, 2024 |
| EFFECT | — | 9999999995-24-001421 | May 8, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-053940 | May 7, 2024 | Mar 31, 2024 |
| 8-K | 8-K | 0000950170-24-053931 | May 7, 2024 | — |
| S-3/A | S-3/A | 0001193125-24-131959 | May 6, 2024 | — |
| CORRESP | — | 0001193125-24-131968 | May 6, 2024 | — |
| CORRESP | — | 0001193125-24-130690 | May 3, 2024 | — |
| CORRESP | — | 0001193125-24-127432 | May 1, 2024 | — |
| ARS | ARS | 0000950170-24-049181 | Apr 26, 2024 | Dec 31, 2023 |